Topic List : Cancer
Caregivers honor cancer patient
Minal Patel, a 26-year-old Packard Children’s patient, has always wanted to become a physician. When her cancer relapsed, her doctors and nurses planned a special way to recognize her goal.
Decoding tumor super-suppression
Stanford scientists have found an answer to one of cancer biology’s toughest and most important questions: How does the body suppress tumors?…
Brain tumor growth stopped
High-grade gliomas, a group of aggressive brain tumors, cease growing in mice if a signaling molecule called neuroligin-3 is absent or its activity is blocked with drugs, a Stanford team has shown.
Gift establishes cancer cell therapy center
Silicon Valley entrepreneur Jeffrey Rothschild and his wife, Marieke, have provided funding for a new venture at Stanford Medicine to test cancer cell therapies.
Helping women identify their risk for cancer
Researchers assigned levels of risk to 25 mutations associated with breast and ovarian cancer in a large, Stanford-led study. The results may be helpful in guiding treatment and screening recommendations.
Young scientists win Parker Institute awards
The awards are designed to help train the next generation of scientists in cancer immunotherapy by supporting promising young researchers doing innovative work that has the potential for great impact.
Data sifting finds hidden gene partnerships
Targeting backup biological pathways often used by cancers can lead to more efficient drug development and less-toxic therapies. Stanford researchers have developed a new way to identify these pathways.
Cancer therapy may work in unexpected way
An antibody to the cell receptor PD-1 may launch a two-pronged assault on cancer by initiating attacks by both T cells and macrophages, a Stanford study has found.
First possible drug treatment for lymphedema
Collaboration between two Stanford labs has resulted in the discovery of a molecular cause for lymphedema and the first possible drug treatment for it.
Fibrotic diseases united by common pathway
A common signaling pathway unites diverse fibrotic diseases in humans, Stanford researchers have found. An antibody called anti-CD47, which is being tested as an anti-cancer agent, reverses fibrosis in mice.